Royal Bank of Canada’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $110K | Sell |
13,487
-2,106
| -14% | -$19.1K | ﹤0.01% | 5067 |
|
|
2025
Q4 | $105K | Sell |
15,593
-1,128,528
| -99% | -$8.51M | ﹤0.01% | 5173 |
|
|
2025
Q3 | $9.92M | Buy |
1,144,121
+66,871
| +6% | +$520K | ﹤0.01% | 2164 |
|
|
2025
Q2 | $6.79M | Buy |
1,077,250
+1,062,449
| +7,178% | +$7.04M | ﹤0.01% | 2330 |
|
|
2025
Q1 | $95K | Sell |
14,801
-6,563
| -31% | -$54.3K | ﹤0.01% | 5254 |
|
|
2024
Q4 | $172K | Sell |
21,364
-7,938
| -27% | -$76.5K | ﹤0.01% | 4937 |
|
|
2024
Q3 | $369K | Buy |
29,302
+5,612
| +24% | +$72.5K | ﹤0.01% | 4346 |
|
|
2024
Q2 | $298K | Sell |
23,690
-38,882
| -62% | -$391K | ﹤0.01% | 4433 |
|
|
2024
Q1 | $299K | Buy |
62,572
+19,376
| +45% | +$89.9K | ﹤0.01% | 4358 |
|
|
2023
Q4 | $208K | Buy |
43,196
+17,338
| +67% | +$106K | ﹤0.01% | 5074 |
|
|
2023
Q3 | $188K | Buy |
25,858
+5,996
| +30% | +$47.9K | ﹤0.01% | 4860 |
|
|
2023
Q2 | $147K | Buy |
19,862
+4,932
| +33% | +$38.8K | ﹤0.01% | 5016 |
|
|
2023
Q1 | $105K | Sell |
14,930
-13,265
| -47% | -$122K | ﹤0.01% | 5142 |
|
|
2022
Q4 | $290K | Sell |
28,195
-11,642
| -29% | -$205K | ﹤0.01% | 4563 |
|
|
2022
Q3 | $726K | Sell |
39,837
-48,476
| -55% | -$2.1M | ﹤0.01% | 3710 |
|
|
2022
Q2 | $4.54M | Sell |
88,313
-49,186
| -36% | -$2.55M | ﹤0.01% | 2182 |
|
|
2022
Q1 | $10.1M | Buy |
137,499
+43,957
| +47% | +$3.92M | ﹤0.01% | 1707 |
|
|
2021
Q4 | $13.4M | Buy |
93,542
+23,690
| +34% | +$4.07M | ﹤0.01% | 1686 |
|
|
2021
Q3 | $14.5M | Buy |
69,852
+26,716
| +62% | +$5.89M | ﹤0.01% | 1564 |
|
|
2021
Q2 | $9.16M | Buy |
43,136
+32,497
| +305% | +$5.95M | ﹤0.01% | 1870 |
|
|
2021
Q1 | $1.93M | Buy |
10,639
+3,493
| +49% | +$696K | ﹤0.01% | 3040 |
|
|
2020
Q4 | $797K | Sell |
7,146
-24,789
| -78% | -$2.63M | ﹤0.01% | 3705 |
|
|
2020
Q3 | $3.46M | Buy |
31,935
+24,792
| +347% | +$3.02M | ﹤0.01% | 2259 |
|
|
2020
Q2 | $595K | Sell |
7,143
-10,217
| -59% | -$391K | ﹤0.01% | 3630 |
|
|
2020
Q1 | $236K | Buy |
17,360
+7,286
| +72% | +$61.7K | ﹤0.01% | 4205 |
|
|
2019
Q4 | $40K | Buy |
10,074
+3,398
| +51% | +$14.7K | ﹤0.01% | 5542 |
|
|
2019
Q3 | $34K | Buy |
6,676
+2,246
| +51% | +$12.3K | ﹤0.01% | 5275 |
|
|
2019
Q2 | $26K | Sell |
4,430
-467
| -10% | -$3.67K | ﹤0.01% | 5580 |
|
|
2019
Q1 | $54K | Buy |
4,897
+1,978
| +68% | +$62.4K | ﹤0.01% | 5116 |
|
|
2018
Q4 | $107K | Sell |
2,919
-188
| -6% | -$7.29K | ﹤0.01% | 4685 |
|
|
2018
Q3 | $117K | Buy |
3,107
+1,012
| +48% | +$28.5K | ﹤0.01% | 4776 |
|
|
2018
Q2 | $56K | Buy |
2,095
+54
| +3% | +$1.82K | ﹤0.01% | 5109 |
|
|
2018
Q1 | $86K | Buy |
2,041
+798
| +64% | +$32.1K | ﹤0.01% | 4776 |
|
|
2017
Q4 | $30K | Sell |
1,243
-804
| -39% | -$19.6K | ﹤0.01% | 5408 |
|
|
2017
Q3 | $46K | Buy |
2,047
+1,290
| +170% | +$28.9K | ﹤0.01% | 5465 |
|
|
2017
Q2 | $17K | Sell |
757
-401
| -35% | -$7.87K | ﹤0.01% | 5601 |
|
|
2017
Q1 | $29K | Sell |
1,158
-238
| -17% | -$6.54K | ﹤0.01% | 5430 |
|
|
2016
Q4 | $35K | Buy |
1,396
+69
| +5% | +$2.01K | ﹤0.01% | 5462 |
|
|
2016
Q3 | $56K | Sell |
1,327
-282
| -18% | -$36.4K | ﹤0.01% | 5111 |
|
|
2016
Q2 | $233K | Sell |
1,609
-182
| -10% | -$20.9K | ﹤0.01% | 4303 |
|
|
2016
Q1 | $184K | Sell |
1,791
-1,134
| -39% | -$122K | ﹤0.01% | 4427 |
|
|
2015
Q4 | $490K | Buy |
2,925
+2,275
| +350% | +$350K | ﹤0.01% | 3795 |
|
|
2015
Q3 | $91K | Buy |
650
+50
| +8% | +$11.2K | ﹤0.01% | 4826 |
|
|
2015
Q2 | $134K | Sell |
600
-15
| -2% | -$2.64K | ﹤0.01% | 4654 |
|
|
2015
Q1 | $102K | Sell |
615
-765
| -55% | -$124K | ﹤0.01% | 4616 |
|
|
2014
Q4 | $164K | Buy |
1,380
+125
| +10% | +$13.1K | ﹤0.01% | 4471 |
|
|
2014
Q3 | $104K | Sell |
1,255
-1,675
| -57% | -$151K | ﹤0.01% | 4596 |
|
|
2014
Q2 | $271K | Sell |
2,930
-2,545
| -46% | -$224K | ﹤0.01% | 3943 |
|
|
2014
Q1 | $496K | Buy |
5,475
+2,140
| +64% | +$239K | ﹤0.01% | 3356 |
|
|
2013
Q4 | $341K | Buy |
3,335
+3,275
| +5,458% | +$231K | ﹤0.01% | 3717 |
|
|
2013
Q3 | $4K | Buy |
60
+50
| +500% | +$2.82K | ﹤0.01% | 5689 |
|
|
2013
Q2 | $0 | Buy |
+10
| New | +$433 | ﹤0.01% | 5839 |
|
Other funds holding NVAX
SCM
VPM
VCM
S
Royal Bank of Canada's NVAX Position: Q1 2026 in Review
Royal Bank of Canada reduced its Novavax (NVAX) stake by 14% in Q1 2026, selling an estimated $19.1K and leaving 13,487 shares worth $110K. The position accounts for ﹤0.01% of the portfolio, ranked #5067.
Royal Bank of Canada first reported a position in NVAX in Q2 2013 and has held it in 52 quarters since. The position peaked at $14.5M in Q3 2021. 258 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.
- Royal Bank of Canada held 13,487 shares of Novavax worth $110K as of Q1 2026.
- Royal Bank of Canada sold 2,106 Novavax shares in Q1 2026, an estimated $19.1K.
- Novavax made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #5067 holding.
- Royal Bank of Canada first reported a position in Novavax in Q2 2013 and has held it in 52 quarters since.
- Royal Bank of Canada's Novavax position peaked at $14.5M in Q3 2021.
- 258 funds tracked by Wall St. Rank held Novavax as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.